OTCMKTS:QPWR QSAM Biosciences (QPWR) Stock Price, News & Analysis → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free QPWR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$6.50▼$8.2552-Week Range N/AVolume133,563 shsAverage Volume68,770 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get QSAM Biosciences alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About QSAM Biosciences Stock (OTCMKTS:QPWR)QSAM Biosciences, Inc. is a holding company, which engages in the process and provision of renewable energy. Its product portfolio includes waste water treatment plants, landfills, and livestock farms. The company was founded by Christopher M. Nelson on August 26, 2004 and is headquartered in Palm Beach, FL.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. QPWR Stock News HeadlinesFebruary 16, 2024 | morningstar.comQSAM Biosciences Inc QSAMFebruary 8, 2024 | msn.comTelix to acquire QSAM Biosciences for $123.1mMay 5, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.November 14, 2023 | msn.comQSAM Biosciences signs term sheet to be acquired by Telix PharmaceuticalsMay 17, 2023 | marketwatch.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Inks Supply Agreement with Leading Nuclear Medicine Pharmacy NetworkMay 13, 2023 | marketwatch.com8-K: QSAM Biosciences, Inc.April 27, 2023 | marketwatch.comQSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam(R)April 5, 2023 | marketwatch.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Phase 1 CycloSam(R) Study Ready to Open Cohort 2 EnrollmentMay 5, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 5, 2023 | marketwatch.comQSAM Biosciences Opens Enrollment of the Second Cohort of Patients in its Phase 1 Study of CycloSam(R) Targeting Metastatic Bone CancerMarch 8, 2023 | msn.comQSAM receives clearance from FDA to expand enrollment criteria for bone cancer treatmentFebruary 24, 2023 | benzinga.comInvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Adds New Trial Site to Expand Study of CycloSam(R) for Bone CancerFebruary 23, 2023 | finance.yahoo.comQSAM Biosciences, Inc. (QSAM) Stock Historical Prices & Data - Yahoo FinanceAugust 16, 2022 | finance.yahoo.comQSAM Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateMay 17, 2022 | finance.yahoo.comQSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate UpdateSee More Headlines Receive QPWR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QSAM Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Waste Management Sub-IndustryN/A Current SymbolOTCMKTS:QPWR CUSIPN/A CIK1310527 Webq2earth.com Phone(561) 693-1423FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDouglas R. BaumChief Executive Officer & DirectorChristopher M. NelsonPresident, Director & General CounselMike VogelSenior Vice President-OperationsWilliam KishVice President-Operations & Business DevelopmentNicole MayerControllerKey CompetitorsAgilyx ASAOTCMKTS:AGXXFBefesaOTC:BFSAFClean TeQOTCMKTS:CTEQFCleanaway Waste ManagementOTCMKTS:TSPCFDaiseki Co.,Ltd.OTCMKTS:DSKIFView All Competitors QPWR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of QSAM Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other QSAM Biosciences investors own include XOMA (XOMA), Morgan Stanley (MS), Cyclone Power Technologies (CYPW), Cameco (CCJ), Actinium Pharmaceuticals (ATNM) and Altisource Portfolio Solutions (ASPS). How do I buy shares of QSAM Biosciences? Shares of QPWR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:QPWR) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldCharles Payne Demystifies OptionsUnstoppable ProsperityThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QSAM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
